Anastasios D Papanastasiou Selected Research

Anastasios D Papanastasiou Research Topics

Disease

12	Neoplasms (Cancer) 02/2024 - 05/2011
6	Breast Neoplasms (Breast Cancer) 11/2022 - 07/2012
3	Inflammation (Inflammations) 01/2022 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 05/2011
1	Laron Syndrome (Syndrome, Laron) 09/2023
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Dementia (Dementias) 01/2019
1	Xerostomia 10/2018
1	Keratoconjunctivitis Sicca 10/2018
1	Adenomyoepithelioma 01/2018
1	Infections 11/2014
1	Chromothripsis 03/2014
1	Melanoma (Melanoma, Malignant) 01/2014
1	Neoplasm Metastasis (Metastasis) 07/2012
1	Necrosis 07/2012
1	Abscess 04/2010
1	Cysts 04/2010
1	Job Syndrome (Hyper-IgE Syndrome) 04/2010
1	Pneumonia (Pneumonitis) 04/2010

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 11/2022 - 10/2008
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 05/2011
3	Messenger RNA (mRNA)IBA 01/2018 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2010
2	Estrogen ReceptorsIBA 01/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2012
2	AutoantibodiesIBA 01/2022 - 10/2018
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 10/2017
2	Codon (Codons)IBA 01/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 10/2017
1	Cell-Free Nucleic AcidsIBA 02/2024
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 09/2023
1	Keratin-7 (Cytokeratin 7)IBA 01/2023
1	Periodic AcidIBA 01/2023
1	MucinsIBA 01/2023
1	SynaptophysinIBA 01/2023
1	TNF Receptor-Associated Factor 3IBA 11/2022
1	OsteopontinIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	resiquimodIBA 01/2022
1	LipofuscinIBA 01/2022
1	LipidsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Gefitinib (Iressa)FDA Link 10/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	CytokinesIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2018
1	CoagulaseIBA 11/2014
1	NucleotidesIBA 03/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	MitogensIBA 01/2014
1	NF-kappa B (NF-kB)IBA 07/2012
1	LigandsIBA 07/2012
1	Protein Isoforms (Isoforms)IBA 07/2012
1	DCC ReceptorIBA 05/2011
1	Netrin-1IBA 05/2011
1	Immunoglobulin E (IgE)IBA 04/2010
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2010
1	AntigensIBA 10/2008
1	EpitopesIBA 10/2008
1	AutoantigensIBA 10/2008

Therapy/Procedure

3	Therapeutics 01/2022 - 10/2008
1	Aftercare (After-Treatment) 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Neoadjuvant Therapy 01/2020
1	Immunotherapy 01/2014
1	Stem Cell Transplantation 10/2008